MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12072-013-9496-2

Медицинская библиотека · Hepatology international · 2013

Strategies to treat interferon-induced graft dysfunction after living donor liver transplantation for hepatitis C.

Ikegami Toru, Wang Huanlin, Yoshizumi Tomoharu, Toshima Takeo, Aishima Shinichi, Fukuhara Takasuke, Furusyo Norihiro, Kotoh Kazuhiro, Shimoda Shinji, Shirabe Ken, Maehara Yoshihiko

СтатьяПеревод в очереди

Аннотация

PURPOSE: Interferon-induced graft dysfunction (IGD) is a poorly defined, unrecognized, but potentially serious condition for patients receiving antiviral drugs after liver transplantation for hepatitis C.

METHODS

We evaluated the characteristics of 80 patients who received pegylated interferon-based antiviral treatment for hepatitis C after living donor liver transplantation (LDLT).

RESULTS

Eight patients experienced IGD either during (n = 6) or after completing (n = 2) antiviral treatment. Pathological diagnosis included acute cellular rejection (ACR, n = 1), plasma cell hepatitis (PCH, n = 2), PCH plus ACR (n = 3), and chronic rejection (CR, n = 2). One patient with CR initially presented with PCH plus ACR and the other presented with ACR; both had apparent cholestasis. The six patients with ACR or PCH without cholestasis were successfully treated by discontinuing antiviral treatment and increasing immunosuppression, including steroids. By contrast, both of the patients with CR and cholestasis experienced graft loss, despite aggressive treatment. Univariate analysis showed that pegylated interferon-α2a-based treatment (75 vs. 26.4 %, p < 0.01) was the only significant factor for IGD, and was associated with decreased 5-year graft survival (93.4 vs. 71.4 %, p = 0.04).

CONCLUSIONS

IGD is a serious condition during or even after antiviral treatment for hepatitis C after LDLT. Early recognition, diagnosis, discontinuation of interferon, and introduction of steroid-based treatment may help to save the graft.

Для цитирования: Ikegami Toru, Wang Huanlin, Yoshizumi Tomoharu, Toshima Takeo, Aishima Shinichi, Fukuhara Takasuke, Furusyo Norihiro, Kotoh Kazuhiro, Shimoda Shinji, Shirabe Ken, Maehara Yoshihiko. Strategies to treat interferon-induced graft dysfunction after living donor liver transplantation for hepatitis C.. Hepatology international. 2013. DOI: 10.1007/s12072-013-9496-2.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.